| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/05/2008 | WO2008066296A1 Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system |
| 06/05/2008 | WO2008066295A1 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system |
| 06/05/2008 | WO2008066294A1 Pharmaceutical composition containing micronized particle of naphthoquinone-based compound |
| 06/05/2008 | WO2008066185A1 Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 06/05/2008 | WO2008066184A1 Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation |
| 06/05/2008 | WO2008066183A1 Skin adhesive preparation comprising stabilized donepezil |
| 06/05/2008 | WO2008066180A1 Skin adhesive preparation comprising stabilized donepezil |
| 06/05/2008 | WO2008066179A1 Percutaneous absorption preparation |
| 06/05/2008 | WO2008066115A1 Adhesive skin patch and method for evaluation of adhesive skin patch |
| 06/05/2008 | WO2008066102A1 Sustained release preparation |
| 06/05/2008 | WO2008065738A1 Bone defect filler, release-controlled carrier, and their production methods |
| 06/05/2008 | WO2008065674A1 Preparation of a free flowing molecular dispersion of clopidogrel base |
| 06/05/2008 | WO2008065660A2 Oxygen supply for cell transplant and vascularization |
| 06/05/2008 | WO2008065652A2 Ros generation by nanoparticles, microbubbles and their use |
| 06/05/2008 | WO2008065506A2 Pharmaceutical compositions comprising nanoparticles comprising enteric polymers and casein |
| 06/05/2008 | WO2008065504A1 Multiparticulates of spray-coated drug and polymer on a meltable core |
| 06/05/2008 | WO2008065502A1 Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein |
| 06/05/2008 | WO2008065492A2 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof |
| 06/05/2008 | WO2008065473A1 Anti-diabetic composition based on the plant genus sutherlandia |
| 06/05/2008 | WO2008065451A2 Compositions comprising macromolecular assemblies of lipid and surfactant |
| 06/05/2008 | WO2008065386A1 Treatment of disease |
| 06/05/2008 | WO2008065369A2 A bleomycin preparation for use against skin tumours |
| 06/05/2008 | WO2008065339A1 Pharmaceutical composition of memantine |
| 06/05/2008 | WO2008065316A2 Ointment compositions comprising a vitamin d derivative |
| 06/05/2008 | WO2008065306A1 Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
| 06/05/2008 | WO2008065247A1 Use of beta-lactamase |
| 06/05/2008 | WO2008065144A2 Galenic formulations of organic compounds |
| 06/05/2008 | WO2008065142A1 Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative |
| 06/05/2008 | WO2008065107A1 Storage stable tablets based on benzimidazole derivatives coated with a gastro-resistant film |
| 06/05/2008 | WO2008065097A2 Stabilized solid pharmaceutical composition of candesartan cilexetil |
| 06/05/2008 | WO2008064854A1 Drug preparation of tramadol and acetaminophen |
| 06/05/2008 | WO2008064815A2 Preparation for transdermally administering galanthamine |
| 06/05/2008 | WO2008064595A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
| 06/05/2008 | WO2008064592A1 A composition comprising chinese traditional medicine as active ingredient for treating cardiovascular diseases and quality control method thereof |
| 06/05/2008 | WO2008064489A1 Probiotics to inhibit inflammation |
| 06/05/2008 | WO2008064475A1 Burn bandage |
| 06/05/2008 | WO2008048801A3 Phenylalkylamino carbamate compositions |
| 06/05/2008 | WO2008048469A3 Controlled-release coated dosage forms containing galantamine |
| 06/05/2008 | WO2008030818A3 Novel liposome compositions |
| 06/05/2008 | WO2008028641A3 Novel nanoparticles |
| 06/05/2008 | WO2008015238A8 Subcutaneous implants releasing an active principle over an extended period of time |
| 06/05/2008 | WO2008015236A8 Subcutaneous implants releasing an active principle over an extended period of time |
| 06/05/2008 | WO2008001200A3 Transdermal composition having enhanced color stability |
| 06/05/2008 | WO2007149316A3 High performance reticulated elastomeric matrix |
| 06/05/2008 | WO2007113856A3 Directly compressible composite for orally disintegrating tablets |
| 06/05/2008 | WO2007103547A3 Acoustically controlled substance delivery device |
| 06/05/2008 | WO2007071261A3 Carboxylic acid esters of mono- and di-glycerides as a dispersing agent |
| 06/05/2008 | US20080132881 Injectable controlled release fluid delivery system |
| 06/05/2008 | US20080132587 Low Peak Exotherm Curable Compositions |
| 06/05/2008 | US20080132585 Separate type medical material |
| 06/05/2008 | US20080132582 Propofol formulation containing reduced oil and surfactants |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132564 Micellar drug delivery vehicles and precursors thereto and uses thereof |
| 06/05/2008 | US20080132533 Solid Dispersion Comprising Tacrolimus and Entericcoated Macromolecule |
| 06/05/2008 | US20080131536 Fermenting licorice root and sodium carbonate in warm water, adding diluted HCl followed by stirring, filtering |
| 06/05/2008 | US20080131535 Skin protection composition |
| 06/05/2008 | US20080131524 Compositions for treatment of viral-induced skin lesions and methods of using same |
| 06/05/2008 | US20080131520 Silk fibroin from domesticated silkworm; sustained release; waste treatment |
| 06/05/2008 | US20080131518 Process for Preparing a Medicament |
| 06/05/2008 | US20080131517 Time-sustained-release formulations comprising a beta-blocker |
| 06/05/2008 | US20080131516 Granule formation |
| 06/05/2008 | US20080131515 Small particle size of emulsified particles and excellent emulsion stability (transparency) even when sodium ascorbate or catechin is added; phospholipid, an oil-based component and a surfactant in specified amount |
| 06/05/2008 | US20080131514 Preservation of bioactive materials by spray drying |
| 06/05/2008 | US20080131513 Sustained-Release Microspheres and Methods of Making and Using Same |
| 06/05/2008 | US20080131511 Use of(-)-S isomer of 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane or salt thereof (YM-796) to accelerate tear and salivary fluid secretion without accompanying sweating; sustained release with a hydrophilic base and a polymeric hydrogel as carrier |
| 06/05/2008 | US20080131508 Oral transmucosal nicotine dosage form |
| 06/05/2008 | US20080131507 Pre-blending a drug susceptible to tackiness such as ibuprofen with an additive such as silica; directly compressing the blend without the need for a granulation step or roller compression |
| 06/05/2008 | US20080131506 and as additive fatty acids or salts, fatty esters, lipid materials, polysaccharides, polyvinylpyrrolidones, acrylic compounds, glycerides, animal proteins or mixtures thereof; sustained release of drug or nutrient; calcium carbonate replaces organic compound normally found in prolonged release dosages |
| 06/05/2008 | US20080131505 Improved compactability profile, lubricant sensitivity, and ejection profile; sugar alcohol is mannitol |
| 06/05/2008 | US20080131504 Short Term Slow Release Drug Delivery System |
| 06/05/2008 | US20080131503 oral administration comprising a fixed dose combination of a first solid pharmaceutical composition containing fenofibrate as the active substance and second solid pharmaceutical composition containing an HMG-CoA reductase inhibitor such as a statin as the active substance, wherein the first dosage |
| 06/05/2008 | US20080131502 Capsule medication administration system and medication administration method |
| 06/05/2008 | US20080131501 enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These formulations may be advantageously used for the treatment of acute neurological conditions, such as migraine. |
| 06/05/2008 | US20080131500 methods of inactivating a protein, such as cleaving a disulfide bond of a protein, that involve contacting the protein with a reducing agent, a denaturant, and a hydroxide ion, wherein the pH of the composition is about 10.0 to about 14.0. Also disclosed are methods of treating or preventing a disease |
| 06/05/2008 | US20080131499 Method and composition for solubilising a biologically active compound with low water solubilty |
| 06/05/2008 | US20080131498 liposome-encapsulated busulphan formulations for parenteral administration are provided, as well as such formulations furthermore comprising glutathione and/or at least one glutathione precursor and a process for manufacture of the preparations. The formulations are stable, have improved biodistribution |
| 06/05/2008 | US20080131497 Formulations of DNase and Methods of Use Thereof |
| 06/05/2008 | US20080131496 topical therapeutically effective amount of melatonin encapsulated in a liposome applied topically to an area of skin affected by immunologic response, radiation treatment induced dermatitis, acne, insect bite or other irritant stimulus such as sunburn in order to reduce itching. |
| 06/05/2008 | US20080131495 method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation. |
| 06/05/2008 | US20080131494 Dermal Penetration enhancers and drug delivery systems involving same |
| 06/05/2008 | US20080131493 multilayered composite sheet for delivering one or more therapeutic agents to the skin is disclosed. The composite sheet comprises a flexible porous polymer with open cells of a sufficient size for holding a therapeutic agent, an encapsulating agent for encapsulating the flexible porous polymer |
| 06/05/2008 | US20080131492 treatment of certain neural disorders/diseases, such as Parkinson's disease and other motor disorders. One aspect of the invention relates to drug compositions and dosage forms comprising said drug composition. Another aspect of the invention relates to methods of manufacturing the drug compositions |
| 06/05/2008 | US20080131490 Stabilized donepezil-containing patch preparation |
| 06/05/2008 | US20080131489 composite structure suitable for making transdermal delivery devices includes in sequence: (a) a liner film layer; (b) a containment layer having from zero to 15 wt. % content of vinyl acetate repeating units, the layer including either a thermal bonding copolyester resin or a combination of an ethylene |
| 06/05/2008 | US20080131488 Medical Tape Preparation |
| 06/05/2008 | US20080131486 Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid mmatrix of a two biodegradable polymer matrix |
| 06/05/2008 | US20080131485 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide |
| 06/05/2008 | US20080131484 Intraocular drug delivery systems |
| 06/05/2008 | US20080131483 Enhancement of Drug Delivery to the Central Nervous System |
| 06/05/2008 | US20080131482 Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix |
| 06/05/2008 | US20080131481 Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| 06/05/2008 | US20080131480 New polyarylates for drug delivery and tissue engineering |
| 06/05/2008 | US20080131478 Methods for Encapsulation of Biomacromolecules in Polymers |
| 06/05/2008 | US20080131474 Promoting cardiac tissue repair while inhibiting or reducing vascular occlusion and/or restenosis |
| 06/05/2008 | US20080131473 Cell-Independent Fabrication of Tissue Equivalents |
| 06/05/2008 | US20080131472 Sulfated Depolymerized Derivatives of Exopolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing Same, and Uses Thereof in Tissue Regeneration |
| 06/05/2008 | US20080131471 Washing clothes along with releasing material containing silver loaded ion exchange particles and hydrophilic binder |
| 06/05/2008 | US20080131467 Oral medication with intense cooling effect; masking unpleasant taste |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131401 Using starch mixture as carrier agent for localizing preferential probiotic organisms |